IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 141 filers reported holding IMMUNOGEN INC in Q3 2014. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,564,915 | -12.3% | 917,764 | +4.3% | 0.01% | -16.7% |
| Q2 2023 | $16,599,939 | +25893.0% | 879,700 | +5189.5% | 0.01% | – |
| Q1 2023 | $63,863 | -81.3% | 16,631 | -75.9% | 0.00% | – |
| Q4 2022 | $341,679 | +155.0% | 68,887 | +145.9% | 0.00% | – |
| Q3 2022 | $134,000 | -16.8% | 28,014 | -21.5% | 0.00% | – |
| Q2 2022 | $161,000 | -88.5% | 35,683 | -87.9% | 0.00% | – |
| Q1 2022 | $1,398,000 | -59.0% | 293,783 | -36.1% | 0.00% | -100.0% |
| Q4 2021 | $3,410,000 | +122.1% | 459,428 | +69.7% | 0.00% | – |
| Q3 2021 | $1,535,000 | +57.4% | 270,687 | +83.0% | 0.00% | – |
| Q2 2021 | $975,000 | +6.3% | 147,933 | +30.6% | 0.00% | – |
| Q1 2021 | $917,000 | -5.7% | 113,277 | -24.7% | 0.00% | – |
| Q4 2020 | $972,000 | +148.0% | 150,478 | +38.1% | 0.00% | – |
| Q3 2020 | $392,000 | +45.2% | 108,931 | +85.6% | 0.00% | – |
| Q2 2020 | $270,000 | +718.2% | 58,706 | +333.2% | 0.00% | – |
| Q3 2019 | $33,000 | -93.5% | 13,551 | -94.2% | 0.00% | -100.0% |
| Q2 2019 | $511,000 | +50.3% | 235,590 | +233.1% | 0.00% | 0.0% |
| Q4 2018 | $340,000 | +178.7% | 70,731 | +449.8% | 0.00% | – |
| Q3 2018 | $122,000 | -79.4% | 12,866 | -78.8% | 0.00% | -100.0% |
| Q2 2018 | $591,000 | +88.8% | 60,794 | +104.3% | 0.00% | 0.0% |
| Q1 2018 | $313,000 | +389.1% | 29,763 | +197.6% | 0.00% | – |
| Q4 2017 | $64,000 | -89.7% | 10,000 | -87.7% | 0.00% | -100.0% |
| Q3 2017 | $620,000 | +566.7% | 81,099 | +518.9% | 0.00% | – |
| Q2 2017 | $93,000 | +86.0% | 13,104 | -46.8% | 0.00% | – |
| Q4 2016 | $50,000 | +28.2% | 24,621 | +67.3% | 0.00% | – |
| Q3 2016 | $39,000 | -71.9% | 14,718 | -5.1% | 0.00% | -100.0% |
| Q1 2015 | $139,000 | -46.3% | 15,512 | -36.6% | 0.00% | -66.7% |
| Q3 2014 | $259,000 | – | 24,479 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TWIN FOCUS CAPITAL PARTNERS, LLC | 140,000 | $2,090,000 | 2.48% |
| BB BIOTECH AG | 3,165,816 | $47,266,000 | 2.44% |
| SECTORAL ASSET MANAGEMENT INC | 3,623,786 | $54,103,000 | 2.22% |
| Lumbard & Kellner, LLC | 81,225 | $1,192,000 | 1.02% |
| Artal Group S.A. | 1,300,000 | $19,409,000 | 0.70% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 100,000 | $1,493,000 | 0.48% |
| Rhenman & Partners Asset Management AB | 73,702 | $1,100,000 | 0.33% |
| PINNACLE ASSOCIATES LTD | 883,647 | $13,193,000 | 0.26% |
| FIRST TRUST ADVISORS LP | 3,608,918 | $53,881,000 | 0.24% |
| Granahan Investment Management | 540,641 | $8,072,000 | 0.22% |